We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Guideline on Clinical Investigations of VTE Products
EMA Updates Guideline on Clinical Investigations of VTE Products
June 7, 2012
The European Medicines Agency (EMA) has updated its draft guideline on clinical investigations of venous thromboembolism (VTE) products, adding new definitions for bleeding events and secondary endpoints to consider for clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor